Aptevo Therapeutics Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Aptevo Therapeutics Inc. (APVO) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-14
- Aptevo Therapeutics Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $157.00K, a 63.91% decline year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.30M.
- Aptevo Therapeutics Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-06-30 was $435.00K.
- Aptevo Therapeutics Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-03-31 was -$1.09M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month |
|---|---|---|
| 2026-06-30 | $157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.15M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$1.30M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $435.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$657.00K 10-Q · filed 2026-08-14 |
| 2025-03-31 | -$1.09M 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |